quinacrine and bexarotene

quinacrine has been researched along with bexarotene in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Af Hällström, TM; Aittokallio, T; Bychkov, D; Eldfors, S; Heckman, C; Horvath, P; Kallioniemi, O; Mirtti, T; Mpindi, JP; Östling, P; Paavolainen, L; Peehl, DM; Rahkama, V; Rannikko, A; Saeed, K; Wennerberg, K; Yadav, B	1

Other Studies

1 other study(ies) available for quinacrine and bexarotene

Article	Year
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer. European urology, 2017, Volume: 71, Issue:3 Topics: Aniline Compounds; Antineoplastic Agents; Bexarotene; Cellular Reprogramming Techniques; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Humans; Kallikreins; Keratin-18; Keratin-5; Male; Organoplatinum Compounds; Oxaliplatin; Precision Medicine; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Quinacrine; Receptors, Androgen; Sulfonamides; Tetrahydronaphthalenes; Tretinoin; Tumor Cells, Cultured	2017

Article

Year

Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer.

European urology, 2017, Volume: 71, Issue:3

Topics: Aniline Compounds; Antineoplastic Agents; Bexarotene; Cellular Reprogramming Techniques; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Humans; Kallikreins; Keratin-18; Keratin-5; Male; Organoplatinum Compounds; Oxaliplatin; Precision Medicine; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Quinacrine; Receptors, Androgen; Sulfonamides; Tetrahydronaphthalenes; Tretinoin; Tumor Cells, Cultured

2017